| Filed On | Filing |
|---|---|
| 05 Nov 2026 |
8-K: Results of Operations and Financial Condition
Revenue of $153 million; Clinical Subscription Revenue of $38 million, up 48% year-over-year |
| 09 Sep 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
On behalf of WW International, Inc. (the “Company”), I am pleased to offer you the position of President and Chief Executive Officer of the Company on the terms and conditions set forth in this letter agreement (this “Agreement”). Capita... |
| 05 Aug 2026 |
8-K: Results of Operations and Financial Condition
Total End of Period Subscribers of 2.5 million; End of Period Clinical Subscribers of 197 thousand, up 55.7% year-over-year |
| 15 Jun 2026 |
8-K: Submission of Matters to a Vote of Security Holders
WW International, Inc. (the “Company”) held its 2026 annual meeting of shareholders on June 12, 2026. At this meeting, the Company’s shareholders (1) elected the persons listed below to serve as directors for a one-year term expiring at ... |
| 15 May 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
| 07 May 2026 |
8-K: Results of Operations and Financial Condition
Total End of Period Subscribers of 2.7 million; End of Period Clinical Subscribers of 197 thousand, up 46% year-over-year |
| 27 Apr 2026 |
8-K: Regulation FD Disclosure
NEW YORK (April 27, 2026) – WW International, Inc. (NASDAQ: WW) (“Weight Watchers” or the “Company”), the global leader in science-backed weight management, today announced that it intends to utilize up to $40 million in cash to prepay a... |
| 20 Apr 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
NEW YORK – April 20, 2026 – WW International, Inc. (Nasdaq: WW) (“Weight Watchers” or the “Company”), the global leader in science-backed weight management, today announced that it has appointed Heather Thiltgen to the Company’s Board of... |
| 17 Apr 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
| 07 Apr 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
New, Independent Directors Bring Deep Consumer, Digital and Turnaround Expertise |
| 03 Apr 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Amendments to Articles/Bylaws; Change in Fiscal Year
Section 1.1. Place of Meetings. Except as otherwise provided in the Third Amended and Restated Articles of Incorporation (as amended, hereinafter called the “Articles”) of WW International, Inc. (hereinafter called the “Corporation”), al... |
| 16 Mar 2026 |
8-K: Results of Operations and Financial Condition
2025 Total Revenue and Adjusted EBITDA1,2 above high end of previously provided guidance |
| 23 Dec 2025 |
8-K: Departure/Election of Directors or Officers; Compensation
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
| 06 Nov 2025 |
8-K: Results of Operations and Financial Condition
End of Period Subscribers of 3.0 million, including Clinical Subscribers of 124 thousand |
| 12 Sep 2025 |
8-K: Departure/Election of Directors or Officers; Compensation
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
| 11 Aug 2025 |
8-K: Results of Operations and Financial Condition
Successful completion of strategic reorganization, reducing debt by $1.15 billion. In connection with emergence on 6/24/25, fiscal Q2 consists of a “Predecessor” period from 3/30/25 to 6/24/25, and a “Successor” period from 6/25/25 to 6/... |
| 08 Jul 2025 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
NEW YORK, N.Y. – JULY 8, 2025 – WW International, Inc. (“WeightWatchers” or the “Company”), the global leader in science-backed weight management, today announced the successful completion of its strategic reorganization process. With si... |
| 25 Jun 2025 |
8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement +6 more
The purpose of the Plan is to aid the Company in recruiting and retaining employees, directors, advisors and consultants and to motivate such employees, directors, advisors and consultants to exert their best efforts on behalf of the Com... |
| 18 Jun 2025 |
8-K: Bankruptcy or Receivership; Regulation FD Disclosure
Upon consideration of the First Amended Joint Prepackaged Plan of Reorganization of WW International, Inc. and Its Debtor Affiliates, dated May 30, 2025, attached hereto as Exhibit A (together with all exhibits thereto, and as may be ame... |
| 12 Jun 2025 |
8-K: Bankruptcy or Receivership; Submission of Matters to a Vote of Security Holders
The Debtors hereby provide supplemental information with respect to the Reorganized Debtors’ business post-emergence, the equity allocation, and the risks associated with holding the New Common Equity. Capitalized terms used herein that ... |
Loading...